The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

Several anti-cancer therapies target the epidermal growth factor receptor (EGFR). Radionuclide imaging of EGFR expression in tumours may aid in selection of optimal cancer therapy. The (111)In-labelled DOTA-conjugated Z(EGFR:2377) Affibody molecule was successfully used for imaging of EGFR-expressin...

Descripción completa

Detalles Bibliográficos
Autores principales: Garousi, Javad, Andersson, Ken G., Dam, Johan H., Olsen, Birgitte B., Mitran, Bogdan, Orlova, Anna, Buijs, Jos, Ståhl, Stefan, Löfblom, John, Thisgaard, Helge, Tolmachev, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519605/
https://www.ncbi.nlm.nih.gov/pubmed/28729680
http://dx.doi.org/10.1038/s41598-017-05700-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519605/
https://www.ncbi.nlm.nih.gov/pubmed/28729680
http://dx.doi.org/10.1038/s41598-017-05700-7

Ejemplares similares